CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy

Conditions: Autoimmune Hemolytic Anemia; CD19 CAR-T Cell Infusion Interventions: Biological: ThisCART19A Sponsors: Institute of Hematology& Blood Diseases Hospital, China; Suzhou Fundamenta Therapeutics Not yet recruiting

https://clinicaltrials.gov/study/NCT06212154

Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials